small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (375)
  • Capabilities (81)
  • Experience (175)
  • Insights & News (4,154)
  • Other Results (74)

Professionals 375 results

Laura Petroff
Laura Petroff
Partner
  • Los Angeles
Email
+1 213-615-1736
vCard

Partner

  • Los Angeles
Dominick P. DeChiara
Dominick P. DeChiara
Partner
  • New York
Email
+1 212-294-2609
vCard

Partner

  • New York
Glenn S. Shubb
Glenn S. Shubb
Managing Director
  • Los Angeles
Email
+1 213-615-1772
vCard

Managing Director

  • Los Angeles
View All Professionals

Capabilities 81 results

Industry

Development & Protection of AI Technologies

Our Intellectual Property (IP) and Privacy teams work closely together to counsel clients in building, protecting, and commercializing proprietary AI technologies and data; the use of third party or open source AI technologies and data; and the implications that these activities may have under privacy laws....Read more

Practice Area

REITs

Our REIT attorneys are experienced in the planning and implementation of a variety of organizational and real estate ownership structures used for REIT formations and transactions. We understand the complex requirements of asset ownership and character of income that must be met to qualify for pass-through tax treatment under the Internal Revenue Code. Our team has extensive experience with IPOs, private placement of debt, securitization of debt, public/private preferred and common equity offerings, PIPE transactions, recapitalizations, trust preferred securities, asset purchase and dispositions, §1031 exchanges, and mergers and acquisitions. Our experience in capital raising (via public and private securities offerings), securitization, and structured finance transactions is just as deep....Read more

Practice Area

Labor & Employment

Our Labor & Employment Practice is one of the largest and most experienced practices among the country’s multi-disciplined law firms. Our attorneys represent global employers of all types and sizes—ranging from the Fortune 100 to privately held startups—often serving as national, regional, or preferred counsel to many of these major employers....Read more

Experience 175 results

Experience

|

December 3, 2025

US Tiger Securities Announced IPO

Winston & Strawn LLP is serving as U.S. securities counsel to US Tiger Securities, Inc., a full-service broker/dealer, in connection with the $10,000,000 initial public offering of SMJ International Holdings Inc., a Singapore-based premium flooring specialist. The Company priced 2,500,000 Class A ordinary shares at US$4.00 per share. The Class A ordinary shares are expected to begin trading on the NYSE American under the ticker symbol “SMJF” on December 4, 2025....Read more

Experience

|

November 19, 2025

Blockfusion Enters into Business Combination with Blue Acquisition Corp.

Winston & Strawn LLP represents Blockfusion, the owner-operator of a strategically located, clean-energy-powered data center, in its announced business combination with Blue Acquisition Corp., a publicly traded special purpose acquisition company. The transaction attributes a pre-money equity value of approximately USD 450 million to Blockfusion and would result in Blockfusion becoming a publicly traded company upon listing....Read more

Experience

|

October 1, 2025

AA Mission Acquisition Corp. II - Initial Public Offering

Winston & Strawn LLP represented AA Mission Acquisition Corp. II, a blank check company, in the recent closing of its $100 million Initial Public Offering (IPO). The offering consisted of 10,000,000 units priced at $10.00 per unit, before deducting underwriting discounts and estimated offering expenses. The units began trading on the New York Stock Exchange (NYSE) under the ticker symbol “YCY.U” on October 1, 2025....Read more
View All Experience

Insights & News 4,154 results

Article

|

January 6, 2026

|

2 Min Read

Piercing the Corporate Veil: A Case Study and Best Practices Checklist

This article was originally published in Corporate Compliance Insights. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only....Read more

Capital Markets & Securities Law Watch

|

December 31, 2025

|

5 Min Read

Section 16 Obligations Expand to Apply to Foreign Private Issuers

On December 18, 2025, as part of the National Defense Authorization Act for fiscal year 2026, the Holding Foreign Insiders Accountable Act (HFIAA) was signed into law. The HFIAA amends Section 16(a) of the Securities Exchange Act of 1934 to require directors and executive officers of foreign private issuers with a class of equity securities registered under Section 12 of the Exchange Act to comply with the same insider reporting rules that apply to U.S. domestic issuers. Beginning in March 2026, covered FPI insiders must publicly disclose their equity ownership and transactions on the same forms used by U.S. issuers—Forms 3, 4, and 5.

Capital Markets & Securities Law Watch

|

December 23, 2025

|

3 Min Read

DTCC Partners with Digital Asset to Tokenize DTC-Custodied U.S. Treasury Securities

On December 17, 2025, the Depository Trust & Clearing Corporation (DTCC) announced a partnership with Digital Asset Holdings (Digital Asset), a developer of distributed ledger technology, to tokenize a subset of U.S. Treasury securities custodied at its subsidiary, the Depository Trust Company (DTC), using Digital Asset’s Canton Network. This announcement follows DTC’s receipt of a No-Action Letter from the U.S. Securities and Exchange Commission (SEC) on December 11, 2025, providing no-action relief allowing DTC to offer a pilot tokenization service for certain highly liquid assets.

View All Insights & News

Other Results 74 results

Site Content

The Corporate Transparency Act
Task Force

Site Content

In Memoriam:
David A. Coulson

Law Glossary

What Is the Purple Book?

Maintained by the FDA, the Purple Book lists biologic products and biosimilar products that FDA has licensed under the Public Health Service Act. In addition, the Purple Book identifies the date each biologic obtained FDA licensure and indicates whether any biosimilar is interchangeable with its associated reference product....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising